Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Proteomic changes of alveolar lining fluid in illnesses associated with exposure to inhaled non-infectious microbial particles.

Teirilä L, Karvala K, Ahonen N, Riska H, Pietinalho A, Tuominen P, Piirilä P, Puustinen A, Wolff H.

PLoS One. 2014 Jul 17;9(7):e102624. doi: 10.1371/journal.pone.0102624. eCollection 2014.

2.

Impact of Epoetin-beta on anemia and health-related quality of life in cancer patients: a prospective observational study using the generic 15D instrument.

Mäenpää J, Puistola U, Riska H, Sintonen H, Saarni O, Juvonen E, Kellokumpu-Lehtinen PL.

Anticancer Res. 2014 May;34(5):2325-9.

PMID:
24778039
3.

[Fluid in the pleural space--from problem to therapy].

Riska H, Saarelainen S.

Duodecim. 2011;127(2):185-90. Review. Finnish.

PMID:
21442868
4.

Anaemia: a rare but neglected problem among Finnish patients receiving chemotherapy for solid tumours.

Kellokumpu-Lehtinen PL, Puistola U, Paija O, Taimela E, Hirvonen O, Raassina S, Riska H.

Support Care Cancer. 2011 Jan;19(1):149-53. doi: 10.1007/s00520-009-0809-x. Epub 2010 Jan 26.

PMID:
20101415
5.

[Bevacizumab in the treatment of non-small cell lung cancer].

Knuuttila A, Rouhos A, Karjalainen EM, Riska H, Pietiläinen M, Paunu N, Salomaa ER.

Duodecim. 2009;125(4):361-8. Finnish.

PMID:
19358416
6.

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer.

Tan EH, Rolski J, Grodzki T, Schneider CP, Gatzemeier U, Zatloukal P, Aitini E, Carteni G, Riska H, Tsai YH, Abratt R.

Ann Oncol. 2009 Jul;20(7):1249-56. doi: 10.1093/annonc/mdn774. Epub 2009 Mar 10.

PMID:
19276396
7.

Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study.

Hillerdal G, Sorensen JB, Sundström S, Riska H, Vikström A, Hjerpe A.

J Thorac Oncol. 2008 Nov;3(11):1325-31. doi: 10.1097/JTO.0b013e31818b174d.

8.

Anemia kiinteiden syöpäkasvainten yhteydessä.

Kellokumpu-Lehtinen P, Puistola U, Paija O, Taimela E, Hirvonen O, Raassina S, Riska H.

Duodecim. 2007;123(18):2239-46. Finnish. No abstract available.

PMID:
18020280
9.

Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer.

Vansteenkiste J, Canon JL, Riska H, Pirker R, Peterson P, John W, Mali P, Lahn M.

Invest New Drugs. 2005 Jun;23(3):263-9.

PMID:
15868384
10.
11.

Studies of cytokine levels in bronchoalveolar fluid lavage from patients with interstitial lung diseases.

Wolff H, Teppo AM, Mutanen P, Sutinen S, Backman R, Sutinen S, Pietinalho A, Riska H.

Scand J Clin Lab Invest. 2003;63(1):27-36.

PMID:
12729067
12.

Tissue polypeptide antigen (TPA), hyaluronan and CA 125 as serum markers in malignant mesothelioma.

Hedman M, Arnberg H, Wernlund J, Riska H, Brodin O.

Anticancer Res. 2003 Jan-Feb;23(1B):531-6.

PMID:
12680141
13.

High pleural fluid hyaluronan concentrations in rheumatoid arthritis.

Söderblom T, Pettersson T, Nyberg P, Teppo AM, Linko L, Riska H.

Eur Respir J. 1999 Mar;13(3):519-22.

14.

Concomitant chemotherapy and IFN-alpha for small cell lung cancer: a randomized multicenter phase III study.

Ruotsalainen TM, Halme M, Tamminen K, Szopinski J, Niiranen A, Pyrhönen S, Riska H, Maasilta P, Jekunen A, Mäntylä M, Kajanti M, Joensuu H, Sarna S, Cantell K, Mattson K.

J Interferon Cytokine Res. 1999 Mar;19(3):253-9.

PMID:
10213464
15.

Irradiation of brain metastases from lung cancer: a retrospective study.

Bergqvist M, Brattström D, Bennmarker H, Wagenius G, Riska H, Brodin O.

Lung Cancer. 1998 Apr;20(1):57-63.

PMID:
9699188
16.

Pleural fluid interferon-gamma and tumour necrosis factor-alpha in tuberculous and rheumatoid pleurisy.

Söderblom T, Nyberg P, Teppo AM, Klockars M, Riska H, Pettersson T.

Eur Respir J. 1996 Aug;9(8):1652-5.

17.

Similar pleural fluid findings in pleuropulmonary tularemia and tuberculous pleurisy.

Pettersson T, Nyberg P, Nordström D, Riska H.

Chest. 1996 Feb;109(2):572-5.

PMID:
8620743
18.

Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis.

Söderblom T, Nyberg P, Pettersson T, Klockars M, Riska H.

Respiration. 1996;63(5):272-6.

PMID:
8884998
19.

Neurone-specific enolase levels in pleural effusions in patients with rheumatoid arthritis.

Nyberg P, Söderblom T, Pettersson T, Riska H, Klockars M, Linko L.

Thorax. 1996 Jan;51(1):92-4.

20.

Effect of early vs late intervention with inhaled corticosteroids in asthma.

Selroos O, Pietinalho A, Löfroos AB, Riska H.

Chest. 1995 Nov;108(5):1228-34.

PMID:
7587421
22.

Alveolar lavage fluid (ALF) of normal volunteer subjects: cytologic, immunocytochemical, and biochemical reference values.

Sutinen S, Riska H, Backman R, Sutinen SH, Fröseth B.

Respir Med. 1995 Feb;89(2):85-92.

24.

Local side-effects during 4-year treatment with inhaled corticosteroids--a comparison between pressurized metered-dose inhalers and Turbuhaler.

Selroos O, Backman R, Forsén KO, Löfroos AB, Niemistö M, Pietinalho A, Aikäs C, Riska H.

Allergy. 1994 Dec;49(10):888-90.

PMID:
7710001
25.

Clinical efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI with volumatic spacer. A 2-year randomized study in 102 asthma patients.

Selroos O, Backman R, Forsén KO, Löfroos AB, Niemistö M, Pietinalho A, Riska H.

Allergy. 1994 Dec;49(10):833-6.

PMID:
7709992
26.

Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.

Pettersson T, Söderblom T, Nyberg P, Riska H, Linko L, Klockars M.

J Rheumatol. 1994 Oct;21(10):1820-4.

PMID:
7837144
27.

Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis.

Selroos O, Löfroos AB, Pietinalho A, Niemistö M, Riska H.

Sarcoidosis. 1994 Sep;11(2):126-31.

PMID:
7809497
28.

The prognostic value of bronchoalveolar lavage in sarcoidosis.

Tukiainen P, Taskinen E, Riska H.

Sarcoidosis. 1994 Mar;11(1):69-72. No abstract available.

PMID:
8036349
29.

High concentrations of eosinophil cationic protein and eosinophil protein X in eosinophilic pleural effusions.

Pettersson T, Riska H, Sutinen S, Klockars M, Peterson C.

Chest. 1993 Feb;103(2):475-8.

PMID:
8432139
30.

[Asthma and working capacity].

Riska H.

Nord Med. 1992;107(4):102-3. Swedish. No abstract available.

PMID:
1561066
31.

Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.

Sovijärvi AR, Reinikainen K, Freudenthal Y, Andersson P, Riska H.

Respiration. 1992;59(5):279-82.

PMID:
1488561
32.

Effects of captopril on blood pressure and respiratory function compared to verapamil in patients with hypertension and asthma.

Riska H, Sovijärvi AR, Ahonen A, Salorinne Y, Sundberg S, Stenius-Aarniala B.

J Cardiovasc Pharmacol. 1990 Jan;15(1):57-61.

PMID:
1688983
33.

Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.

Pettersson T, Fröseth B, Riska H, Klockars M.

Chest. 1988 Nov;94(5):1037-9.

PMID:
3180855
34.

[An examination of pleural effusion].

Pettersson T, Riska H.

Duodecim. 1988;104(6):386-91. Finnish. No abstract available.

PMID:
3181053
35.

Tuberculosis and renal allograft transplantation.

Riska H, Grönhagen-Riska C, Ahonen J.

Transplant Proc. 1987 Oct;19(5):4096-7. No abstract available.

PMID:
3314000
36.

Plasmapheresis for idiopathic thrombocytopenic purpura unresponsive to intravenous immunoglobulin.

Pettersson T, Riska H, Nordström D, Honkanen E.

Eur J Haematol. 1987 Jul;39(1):92-3. No abstract available.

PMID:
3653382
37.

[Diagnosis of lung tumors].

Riska H.

Duodecim. 1987;103(23-24):1479-84. Finnish. No abstract available.

PMID:
3455381
39.
40.

[Acute tubulointerstitial nephritis following treatment with rifampicin].

Riska H, Tornroth T.

Bull Int Union Tuberc. 1984 Sep;59(3):148-9. French. No abstract available.

PMID:
6518324
41.
42.

Alpha1-antitrypsin: PI type and lung tuberculosis. A negative report.

Backman R, Riska H, Fröseth B, Hellström PE.

Eur J Respir Dis. 1983 Jan;64(1):58-61.

PMID:
6600682
43.

[Glomerulonephritis caused by basal membrane antibodies].

Kurki P, Helve T, van Bonsdorff M, Törnroth T, Pettersson E, Wegelius O, Riska H, Miettinen A.

Duodecim. 1983;99(3):225-30. Review. Finnish. No abstract available.

PMID:
6347640
44.

Cellular immunity during follow-up of patients with sarcoidosis of varying duration.

Selroos O, Nikinmaa B, Koivunen E, Riska H, Tiitinen H, Weber T.

Clin Exp Immunol. 1982 Oct;50(1):25-33.

45.

Fibronectin in exudative pleural effusions.

Klockars M, Pettersson T, Vartio T, Riska H, Vaheri A.

J Clin Pathol. 1982 Jul;35(7):723-7.

46.

Beta 2 microglobulin in pleural effusions.

Riska H, Pettersson T, Fröseth B, Klockars M.

Acta Med Scand. 1982;211(1-2):45-50.

PMID:
6176099
47.

PHA and PPD reactivity of lymphocytes in pleural effusions.

Pettersson T, Klockars M, Riska H.

Chest. 1981 Jul;80(1):44-7.

PMID:
7249711
48.

Diagnostic value of total and differential leukocyte counts in pleural effusions.

Pettersson T, Riska H.

Acta Med Scand. 1981;210(1-2):129-35.

PMID:
7293822
49.

Assessment of the tuberculosis agglutination test.

Riska H, McIllmurray M, Krambovitis E, Fröseth B, Hellström PE.

Eur J Respir Dis. 1980 Dec;61(6):310-4.

PMID:
6781915
50.

[Tuberculosis and renal transplantation].

Riska H, Kuhlback B.

Bull Int Union Tuberc. 1979 Jun;54(2):174-5. French. No abstract available.

PMID:
393331

Supplemental Content

Support Center